VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma
- 18 December 2001
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 196 (2), 186-193
- https://doi.org/10.1002/path.1034
Abstract
Mutations of the von Hippel‐Lindau (VHL) gene are considered critical for the initiation of clear cell renal cell carcinoma. The VHL protein is involved in regulation of the cell cycle and neo‐vascularization. In this study, the association of VHL mutations with tumour cell proliferation, angiogenesis, and clinical outcome was analysed in 113 clear cell renal cell carcinomas. The degree of angiogenesis and tumour cell proliferation was immunohistochemically determined by counting microvessels (microvessel density, anti‐CD34 antibody) and cells with proliferating activity (Ki‐67 labelling index, MIB‐1 antibody). Forty‐eight different VHL sequence alterations were found in 38 of 113 patients (34%) by direct sequencing. Nineteen VHL mutations were frameshifts and nonsense mutations, predicted to change the open reading frame of VHL. These ‘loss‐of‐function’ mutations correlated with worse prognosis in univariate analysis (p=0.02). Tumour grade, stage, microvessel density, and tumour cell proliferation were not associated with VHL alterations. These findings may indicate that ‘loss‐of‐function’ VHL mutations are involved in the progression of a clear cell renal cell carcinoma subset, whereas regulation of angiogenesis and proliferation of renal carcinoma in vivo is apparently not directly influenced by VHL alterations. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 32 references indexed in Scilit:
- The von Hippel–Lindau Tumor Suppressor GeneExperimental Cell Research, 2001
- The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activityGenes & Development, 1999
- PREVALENCE, MORPHOLOGY AND BIOLOGY OF RENAL CELL CARCINOMA IN VON HIPPEL-LINDAU DISEASE COMPARED TO SPORADIC RENAL CELL CARCINOMAJournal of Urology, 1998
- Vascular Endothelial Growth Factor Expression is Increased in Renal Cell CarcinomaJournal of Urology, 1997
- Angiogenesis in Bladder Cancer: Relationship Between Microvessel Density and Tumor PrognosisJNCI Journal of the National Cancer Institute, 1995
- Somatic mutations of the von Hippel — Lindau disease tumour suppressor gene in non-familial clear cell renal carcinomaHuman Molecular Genetics, 1994
- Mutations of the VHL tumour suppressor gene in renal carcinomaNature Genetics, 1994
- Identification of the von Hippel-Lindau Disease Tumor Suppressor GeneScience, 1993
- Vascular permeability factor mRNA and protein expression in human kidneyKidney International, 1992
- Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinomaNature, 1987